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WHAT THIS PAPER ADDS 
 
Masseter muscle area (MA) can be reliably measured from preoperative computed 
tomography angiography and is a significant predictor of long-term mortality after carotid 
endarterectomy independent of other risk factors, anthropometric measures and dental 
status. To understand its potential in risk stratification and long term mortality, the results 
need to be validated in independent cohorts and studies powered to stratify for different 
indication categories.  
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ABSTRACT 
 
Objectives. Sarcopenia is a predictor of mortality in elderly patients. Masseter area (MA) 
reflects sarcopenia in trauma patients. We hypothesized that MA and density (MD) could 
be reliably evaluated from preoperative computed tomography angiography (CTA) scans 
and that they predict postoperative survival in carotid endarterectomy (CEA) patients. 
Methods. Observational registry study. Patients (n=242) were operated due to 
asymptomatic stenosis (n=32, 13.2%), amaurosis fugax (n=41, 16.9%), transient ischemic 
attack (TIA) (n=85, 35.1%) or ischemic stroke (n=84, 34.7%). Internal carotid artery (ICA) 
stenoses were angiographically graded. Intraclass correlation coefficient (ICC) was used 
to analyze measurement reliability by three independent observers. Cox regression 
analysis was used to study the effect of MA and MD on survival (hazard ratio, HR). 
Results. The median age was 71.0 years (IQR 13.0) and follow-up time was 68.5 months 
(range 3-163 months) and at the end of follow-up (1.10.2017) 104 (43.0%) had died 
according to National Population Register. Average MA (MAavg, mean of left and right 
MA; median 394.0; IQR 110.1 mm2) and MD (MDavg, mean of left and right MD; median 
53.5 HU; IQR 16.5 HU) could be measured with excellent reliability (ICC>0.865, p<0.001 
for all). In multivariable analyses only body surface area (BSA) (p<0.0001) and dental 
status were associated with MAavg (p=0.021). Increased MAavg predicted lower mortality 
(HR 0.76, 95% CI 0.61-0.96, p=0.023) independent of age (HR 1.05, 95%CI 1.02-1.07, 
p=0.001), female gender, BMI, renal insufficiency, ipsilateral stenosis, indication category, 
and presence of teeth. MDavg did not associate with mortality. In further adjustment BSA 
(the most significant determinant of MAavg) did not alter the association between MAavg 
and mortality (0.75, 95% CI 0.58-0.97, p=0.031). Conclusions. Average masseter area 
but not density measured from preoperative CTA-scan provides a reliable estimate of 
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postoperative long-term survival in CEA patients independent of other risk factors, 
anthropometric measures and dental status. 
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INTRODUCTION 
 
The net benefit from carotid endarterectomy (CEA) is critically dependent on length of 
postoperative survival 1 which in turn is influenced by several factors. Such factors include 
age, cardiovascular risk factors, chronic obstructive pulmonary disease, renal disease, 
body mass index (BMI), absence of statin use and contralateral carotid occlusive disease 
1–5. 
 
The biological state of reduced physiologic reserve and increased vulnerability associated 
with age, i.e. frailty, reflects subclinical cardiovascular disease and has been found better 
than traditional surgical risk scores in estimating postoperative survival 6–10. Frailty is an 
independent predictor of postoperative mortality in cardiovascular patients doubling the 
risk for mortality and morbidity in patients with stable cardiovascular disease, acute 
coronary syndromes, heart failure and surgical and other interventions 9. Frailty can be 
estimated by measuring loss of muscle mass, i.e. sarcopenia, walking speed and daily 
activity 9. 
 
Paraspinal muscle mass evaluated from computed tomography (CT) images predicted 
survival in patients undergoing elective open and endovascular AAA repair 11,12 and in 
general surgery, and vascular patients 13. Similarly, masseter muscle area measured from 
CT images predicted mortality and correlated well with psoas muscle area in elderly 
patients subjected to blunt trauma 14 and traumatic brain injury 15. In line with this, 
masseter muscle tension, chewing ability, dental status and physical fitness have 
previously been shown to be closely associated in elderly care home residents 16.   
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Sarcopenia related to stroke differs from that related with aging in that it is characterized 
by rapid loss of muscle mass, structural alterations in the muscle and bilateral difference in 
physical and functional performance determined by the brain lesion whereas aging-related 
sarcopenia occurs slowly without structural alterations or bilateral differences 17. In stroke 
patients, imbalanced neurovegetative status may also induce a direct catabolic signal to 
the muscle 17. Sarcopenia related to stroke is likely unilateral while that related with aging 
and frailty is reflected bilaterally. 
 
At present, sarcopenia is not preoperatively evaluated nor is the evaluation easy to 
implement in clinical practice. Furthermore, to the best of our knowledge, no data exists on 
the effect of sarcopenia on postoperative long-term survival after carotid endarterectomy 
which is an important factor when considering the net benefit from carotid surgery. We 
hypothesized that sarcopenia could be easily evaluated from digital preoperative routine 
CT angiography (CTA) scans by measuring masseter muscle area (MA) and density (MD) 
and that it is an independent predictor of postoperative survival. The purpose of this study 
was, firstly, to ascertain the reliability of masseter muscle area and quality measurements 
from preoperative CTA scans of carotid endarterectomy patients. Secondly, the study 
sought to determine the association of sarcopenia represented by these parameters with 
long-term postoperative mortality in a cohort of patients treated for carotid stenosis.  
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MATERIALS AND METHODS 
 
Consecutive patients from the prospective vascular registry of Tampere University Hospital 
(TAUH) subjected to carotid endarterectomy during years 2004-2010 (n=382) were 
retrieved, and those with available digital preoperative computed tomography (CT) and CT 
angiography (CTA) scans (n=242, 63.4%) comprised the final study population. CTA was 
implemented in our clinical practice during 2004, therefore the majority of excluded 
patients were operated during the early years from 2004 to 2006 (n=93). The 
demographics, risk factors, indications and degrees of carotid stenoses of excluded 
patients (n=140, 36.7%) did not differ significantly from the included patients 
(Supplementary table 1). Since patient data were recorded in the prospective register 
during the operation and no patients died during the operation, the database comprises all 
the operated patients. Our indications were in line with published guidelines 18. 
Cardiovascular risk factors obtained from the vascular registry were defined based on 
previous diagnoses and current medication as follows: diabetes (DM, diagnosis/insulin or 
oral hypoglycemic medication), arterial hypertension (HTA, diagnosis/antihypertensive 
medication), cardiac risk factor (diagnosis of myocardial infarction, coronary intervention, 
angina pectoris, ischemia on electrocardiography, congestive heart failure), pulmonary risk 
factor (diagnosis of chronic obstructive pulmonary disease), renal risk factor (diagnosis of 
renal insufficiency), peripheral arterial disease (PAD, diagnosis/peripheral vascular 
intervention or amputation) and dyslipidemia (diagnosis/antihyperlipidemic medication). 
Smoking was defined as smoking within last 5 years or current smoking.  
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Standard protocol approvals 
The study was approved by the Ethics Committee of TAUH and was conducted adhering 
to the principles of the Helsinki declaration.  
 
Radiological assessment 
All study patients were routinely subjected to brain CT and CT angiography. Internal 
carotid artery (ICA) stenoses were determined (NASCET-criteria) and categorized (<50%, 
50-69%, 70-99% and 100%) 19 by a neurointerventional radiologist (JPP). In a pilot 
analysis of a random set of 30 patients by three independent observes before and after 
sagittal and coronal tilt adjustment, head tilt was found to have a significant effect on MA 
measurements. Therefore, tilt alignment of the CTA sections was made according to a 
tangent along the lower border of arcus zygomaticus in sagittal- and along the lowest point 
of orbitae in coronal planes and measurements were made 20 ± 2 mm below the arcus by 
outlining the outer surface of masseter muscle along the fascia after which the image 
analysis program automatically calculated the area (mm2) and mean density (Hounsfield 
Unit, HU) across the region of interest (Figure 1). Thereafter, 30 CTA scans were first 
randomly selected and the analysis performed in a random and blinded fashion by three 
independent observers and reliability was assessed by intraclass correlation coefficient 
analysis (ICC) for both MA and MD measurements. Consequently, after confirmation of 
excellent repeatability, a single rater proceeded with the rest of the scans. The presence of 
teeth was scored in three categories: 1) no teeth, 2) any missing teeth and 3) no evidence 
of missing teeth (Figure 1). Average MA (MAavg, mean of left and right MA) and MD 
(MDavg, mean of left and right MD) were calculated. 
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Survival and causes of death 
Comprehensive long-term survival data on status of the patient (alive/dead) and date of  
death was obtained from the TAUH patient record database at 1.10.2017 which is updated  
in a continuous fashion by the National Population Register. Patients were considered to  
be alive if there was no date of death available in the register at 1.10.2017, i.e. the last  
date known to be alive. A possible delay of data transfer from date of death to the National  
Population Register is within 1-3 weeks. Therefore, the register was reviewed at 1.11.2017  
to ensure that all delayed information on deaths until 1.10.2017 was recorded. This  
database provided full coverage of all the patients included in the study. In Finland, the  
death certificates are mandatory and the data on deaths is without missing cases. The 
outcome event was all cause death. The causes of death based on International Statistical 
Classification of diseases and Related Health Problems (on ICD-9 and ICD-10) 
classifications were obtained and divided further into cardiac (coronary artery disease, 
valvular heart disease, arrhythmia and congestive heart disease), cerebral (ischemic or 
hemorrhagic stroke, cerebral bleeding, vascular dementia), peripheral vascular (peripheral 
arterial disease, aneurysms) cancer, infection, trauma and other categories (Statistics 
Finland). 
 
Statistical analysis 
The statistical software used for analyses was SPSS 24 for Mac OS X. Continuous 
variables were analyzed with Mann-Whitney U-test, and Kruskall-Wallis test for 
independent samples and Wilcoxon signed-rank test for related samples. Intraclass 
correlation coefficient (ICC) was utilized to analyze reliability, i.e. intra- and interobserver 
variability of the measured parameters (areas, densities) measured by three independent 
observers. The two-way random single measurement model was selected and both 
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consistency and absolute agreement were calculated along with 95% confidence intervals. 
ICC was rated as poor (less than 0.40), fair (0.40-0.59), good (0.60-0.74) and excellent 
(0.75-1.00). Normal distribution of CT-variables was ascertained by visually and by 
Levene’s test. The association between clinical characteristics and masseter area and 
density was analyzed with adjusted and unadjusted linear regression analysis. Predictors 
of survival were analyzed using Cox regression proportional hazards analysis first as 
univariable analyses. The effect of age, gender, BMI, body surface area (BSA), and tooth 
loss on CT variables were examined, and included in the multivariable models due to their 
strong a priori association with masseter parameters 20. Testing of the proportional 
hazards assumption was based on log-log-plots and the correlation of survival rankings 
with Schoenfeld residuals. All variables except for age fulfilled this assumption. 
Consequently all multivariable models using Cox-regression were performed with age as a 
time-dependent covariate. Kaplan-Meier survival analysis was utilized to plot the overall 
survival. Multivariable models testing the independent associations of risk factors with 
mortality were adjusted with factors associating nominally with mortality (P<.1) in 
univariable analysis. Missing values for ipsilateral stenosis (n=32) and dental status (n=33) 
were replaced by values calculated by multiple imputation (mice package for R) 21. 
Subjects with a transient event as an indication (amaurosis fugax and transient ischemic 
attack) were pooled to a single category because the mortality risk attributable to these 
events was identical. Age, gender, body surface area (BSA) and dental status were 
included in the multivariable models due to their strong a priori association with masseter 
parameters 20. For estimation of BSA (and BMI) body weight and height was available only 
for a subpopulation (n=158, 65.3%). Due to the large amount of missing data, BSA was 
included in the analyses separately and without replacing missing values. The reported 
hazard ratios (HRs) related to main exposure variables (MAavg and MDavg) correspond to 
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one standard deviation increase in exposure variables. Cox regression model with 
penalized splines were used to evaluate (plot) the relationship between masseter area and 
mortality (psplines package for R). According to power analysis based on a pilot study of 
100 patients, 242 patients were needed (power of 0.9) to detect a significant difference 
(alpha=0.05) in postoperative survival between different MA and MD categories.  
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RESULTS 
 
Patient characteristics 
The median age of the patients was 71.0 years (IQR 13.0). Less than one third of the 
patients were women (29.8%) and the majority of patients had hypertension (76.9%), 
cardiac risk factor (52.9%), dyslipidemia (55.8%), ipsilateral stenosis of 70-99% (85.7%), 
and contralateral stenosis of <50% (55.3%). The main indications for surgery were TIA 
(35.1%) and ischemic stroke (34.7%) while a minority of the operations was due to 
asymptomatic stenosis (13.2%). The side of the operation was left in 55.0% and right in 
45.0% of cases (Table 1). A majority of the patients were on beta blockers (62.2%), statins 
(87.2%), antiaggregatory medication (73.1%), anticoagulants (37.8%), antihypertensives 
(75.6%) whereas a smaller group received oral antidiabetic medication (25.6%) or insulin 
(16.0%).  
 
Determinants of masseter area 
In univariable analyses the strongest factors associated with with MAavg were BSA, 
gender, age and dental status (p<0.001 for all) (Table 2). In multivariable analyses, the 
only significant factors linked to MAavg were BSA (p<0.001) and dental status (p=0.021). 
For MDavg, the associating factors were gender, dental status and age (p<0.01 for all 
comparisons in univariate analyses as well as in multivariable analysis (Table 2). Overall, 
BSA showed clearly stronger association with MAavg when compared to BMI. BMI did not 
correlate significantly with MDavg.  
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Inter- and intraobserver variability of the CT measurements 
MAavg and MDavg demonstrated excellent reliability based on ICC analysis by three 
independent observers (ICC 0.865-0.971 and p<0.001 for all) (Table 3). 
 
Association of preoperative masseter area and density with long-term mortality 
The median follow-up time was 68.5 months (range 3-163 months). During the follow-up, 
104 patients (43.0%) of the study population died. No patients were lost during follow-up. 
A Kaplan-Meier survival plot is presented (Figure 2). 
 
In univariable analysis, MAavg associated significantly with mortality with one SD increase 
corresponding with a lower risk for death (HR 0.72, with 95% CI 0.59-0.88, p=0.001) 
(Table 4). MDavg was not significantly connected to mortality (HR 0.92, 95% CI 0.76-1.12, 
p=0.423) (Table 4). 
 
Factors associated significantly with the measured CT parameters (MAavg and MDavg) 
and factors nominally connected (p<0.1) to mortality in univariable analyses (age, BMI, 
BSA, renal risk factor, ipsilateral stenosis, indication category, teeth) (Table 4) were 
selected for multivariable analysis. In the resulting multivariable Cox regression analysis, 
increased MAavg remained a predictor of lower mortality (HR 0.76, 95% CI 0.61-0.96, 
p=0.023) independent of age (HR 1.05, 95%CI 1.02-1.07, p=0.001), female gender, BMI, 
renal insufficiency, ipsilateral stenosis, indication category, and presence of teeth (Table 
4). In a similar analysis, MDavg did not associate with mortality (HR 1.01, 95% CI 0.81-
1.26, p=0.942). The development of risk of death across the continuum of MAavg shows 
an inverse linear relationship between MAavg and mortality with possible tendency for 
exponential growth in the risk of death when approaching the lowest end of the MAavg 
 14 
range (Figure 3). The risk of death was linearly associated with age (Supplementary 
Figure 1).  
 
In order to verify that masseter area associates with mortality also independently of BSA, 
which was the most significant determinant of MAavg, the same multivariable analysis was 
repeated in a subpopulation with available BSA measurement (n=182, representing 63.6% 
of the entire study population). Despite the lower sample size, the association persisted 
(0.75, 95% CI 0.59-0.97, p=0.030).  
 
Causes of death 
Of the 104 dead patients, the causes of death were cardiovascular in 29.8% subclassified 
further into cerebral (13.5%), cardiac (15.3%), and peripheral vascular (1.0%) causes. 
Remaining deaths were due to cancer (7.7%), infections (1.0%), trauma (1.0%), and other 
causes (5.8%). 
 
 
 
 
 
 
 
 
 
 
 
 15 
DISCUSSION 
 
According to our results, average masseter muscle area (MAavg) and density (MDavg) 
can be easily and reliably measured after sagittal and coronal tilt adjustment below the 
zygomatic arch from routine preoperative CTA images in carotid endarterectomy patients. 
The independent factors contributing to MAavg are BSA and dental status while for MDavg 
these are gender, dental status and age. Increased MAavg remains a predictor of lower 
mortality independent of age, female gender, BMI, renal insufficiency, ipsilateral stenosis, 
indication category, and presence of teeth whereas MD did not associate with mortality. 
This effect remains independent of BSA which is the most significant determinant of 
masseter area. 
 
Our results of an inverse relationship between MAavg and mortality concur with previous 
studies which found MA to predict mortality in elderly patients subjected to blunt trauma 14 
and to traumatic brain injury 15 and this, in turn, suggests that MA could be used as a 
surrogate for sarcopenia. As in our study, the association has been mostly uninfluenced by 
age suggesting that despite correlating with age, masseter area provides independent 
prognostic value when predicting death after trauma or after CEA. In the study by Hu et al. 
15, sarcopenia was defined as a decrease in masseter area of one standard deviation or 
more from the sex-based mean. The mean MA in these sarcopenic patients was 281 mm2 
in men and 224 mm2 in women and they were at increased risk of 30 day mortality (80.0% 
vs. 50.6%) compared to those with greater MA 15. This finding is in line with our analyses 
showing the inverse association between MA and mortality and suggests that there may 
be a different threshold for increased mortality according to gender. The present study was 
not powered to analyze gender differences and the association of MAavg with mortality 
 16 
persisted despite adjustment by gender. In addition to age and gender, other parameters 
with strong a priori association with masseter parameters (BMI, body surface area (BSA), 
tooth loss)  were also examined and included in the multivariable models 20. In the present 
study, most of the significant risk factors previously associated with perioperative risk and 
long term risk among CEA patients in large registry studies and clinical trials 22,23 were also 
recorded and considered in the analyses. Although some of the previously discovered risk 
factors were not associated with the risk of long term mortality (contralateral stenosis and 
BMI) in our study, these factors were recorded to the vascular registry online (i.e. at the 
time of the operation) by treating surgeons and thus with no information of the future 
outcomes. The smaller sample size in our study as compared to the previous large trials 
and registry studies, most likely explains the lack of power to detect significant 
associations between these factors and mortality. The previous observation on the effect 
of age, gender and dental status on MA and MD 20 was replicated in the present study 
which supports our observations and methodology. There were no interactions between 
age and MA that would suggest the association between MA and mortality would be 
influenced by age. The age and MA associated significantly but both also independently 
with death in the same model which confirms that they provide information that is 
independent regarding survival. Our exploratory analysis showed that there is no clear cut-
off for risk across the continuum of masseter area which suggests that categorization of 
masseter area would lead to better risk stratification results. 
 
The primary shortcoming of our study is that it was conducted retrospectively. However, 
the prospective vascular registry used is annually audited for data loss and consistency. In 
addition, all data entries on surgical operations are made already in the operation room to 
ensure all operated patients are entered. All vascular patients are treated in a single 
center, and the patient sample in this study was collected from a cohort comprising all 
 17 
consecutive carotid endarterectomy patients with CTA imaging available. No patients died 
within 30 days from the operation. During the study period, carotid artery stenting was 
performed only seldom and these cases were excluded from the analysis. We started 
using CTA for the diagnostics in 2004. Therefore the majority of excluded patients are 
those treated at the beginning of the study period. We found no differences in 
demographics, risk factors, indications or degrees of carotid stenosis between those 
included and excluded in the study which makes availability of CTA an unlikely source of 
bias. In Finland, determination of cause of death has been based on autopsy in 
approximately 30% of all deaths in the past two decades (www.tilastokeskus.fi) which is 
high compared with other European countries. The death certificates of all deceased, 
whether or not they underwent autopsy, are reviewed by the district forensic physician and 
therefore the amount of patients with missing date or cause of death is negligible. The 
potential bias caused by delayed entry of date of death into the National Population 
Register was eliminated by re-checking the information 1 month after end of follow-up. The 
official cause of death has been demonstrated to be an accurate means of evaluating 
disease specific mortality in Finland24. This adds to the reliability of the present study. Our 
study patients were of Caucasian origin and with respect to stroke cases, limited to those 
with mild-to-moderate strokes, which restricts the generalizability of our results. Finally, as 
postoperative CTA imaging was not routinely performed, the effect of the operative 
procedure itself on MA and MD could not be estimated although it is an interesting future 
research topic. 
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SUMMARY AND CONCLUSIONS 
 
-After sagittal and coronal tilt correction, MA and MD can be reliably measured from 
preoperative routine CTA images 
- MAavg but not MDavg provides long-term predictive value independent of age, female 
gender, BMI, renal insufficiency, ipsilateral stenosis, indication category, and presence of 
teeth independent of BSA, which is the most significant determinant of masseter area.  
-Results need to be validated in independent cohorts and studies powered to stratify for 
different indication categories. 
 
Average masseter area but not density measured from a preoperative CTA-scan provides 
a reliable estimate of postoperative long-term survival in CEA patients independent of 
other risk factors, anthropometric measures and dental status. 
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FIGURE LEGENDS 
 
Figure 1. Representative preoperative images of carotid endarterectomy patients 
demonstrating the sagittal tilt and coronal tilt measurement (a), the measurement of 
masseter area and density before and after tilt correction (b) where masseter area (A) and 
density is shown. The grading of presence of teeth: no teeth any missing teeth, and no 
evidence of missing teeth (c). 
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Figure 2. Kaplan-Meier survival plot of carotid endarterectomy patients. 
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Figure 3. The development of risk of death (hazard rate) across the continuum of average 
masseter area (mm2) in carotid endarterectomy patients. The model was adjusted with 
age, gender, BMI, renal insufficiency, ipsilateral stenosis, indication category and dental 
status. 
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Table 1. Characteristics of carotid endarterectomy patients. 
                                        
Risk factor                           n=242                  
Age, median (IQR)              71.0  (13.0) 
BMI, median (IQR)              26.8  (5.6)               
BSA, median (IQR)              1.9    (0.3)       
Female, n (%)                      72     (29.8)                   
DM, n (%)                            71     (29.3)                   
HTA, n (%)                          186   (76.9)                   
Cardiac, n (%)                     128   (52.9)                   
Dyslipidemia, n (%)             135   (55.8)                   
Renal, n (%)                        5       (2.1)                     
PAD, n (%)                          37     (15.3)                   
Pulmonary, n (%)                 25     (10.3)                   
Smoking, n (%)                    68     (28.1)                    
 
IL-stenosis                                                                
<50%, n (%)                        2       (0.9)                       
50-69%, n(%)                      28     (14.3)                   
70-99%, n (%)                     180   (85.7)                     
100%, n (%)                        0       (0)                         
 
CL-stenosis                                                              
<50%, n (%)                       134    (55.3)                        
50-69%, n (%)                    64     (26.4)                    
70-99%, n (%)                    34      (14.0)                    
100%, n (%)                       10      (4.1)                      
 
Indication                                                  
Asymptomatic, n (%)          32      (13.2)                    
Amaurosis, n (%)                41      (16.9)                    
TIA, n (%)                           85      (35.1)                     
Ischemic stroke, n (%)        84      (34.7)                     
 
Side (L/R)    
Right, n (%)                        109      (45.0) 
Left, n (%)                           133      (55.0)   
 
Body mass index (BMI), Body surface area (BSA), Diabetes mellitus (DM), hypertension (HTA), cardiac risk 
factor (diagnosis of myocardial infarction, coronary intervention, angina pectoris, ischemia on 
electrocardiography and congestive heart failure), renal risk factor (diagnosis of renal insufficiency), peripheral 
arterial disease (PAD), ipsilateral (IL), contralateral (CL), transient ischemic attack (TIA). Side (L/R): the side of 
the index operation.  
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Table 2. Radiological characteristics of carotid endarterectomy patients. 
                                        
                                            Age                         BSA                     Gender               Teeth category 
 
                All                  T1   T2   T3   p         T1  T2  T3      p          M    F      p          1      2     3      p        
                                                                                                  
MAavg    395.0  (110.1)  423 404 362 <.001  345 389 446  <.001   420 349  <.001   371  394 441  <.001 
MDavg    53.5   (16.5)     59   53   49   <.001  55   58   58    NS      55   49    <.010  48    57   59     <.001   
                                                                       
Masseter average area (MAavg, mm2) and masseter average density (MDavg, Hounsfield Units) are presented  
as medians (interquartile range) in all patients and as medians and tertiles indicated as T1, T2 and T3  
according to age, body surface area (BSA), in male (M) and female (F) genders and in different teeth  
categories (1=no teeth, 2=any missing teeth and 3=no evidence of missing teeth according to computed  
tomography analysis). P-values are calculated for linear trend using linear regression analysis. 
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Table 3. Intraclass correlation coefficient (ICC) analysis of preoperative CT-measurements 
of masseter muscles of carotid endarterectomy patients.  
                                        
Variable               ICCa   p           ICCb   p      
                                                                                                  
MAdx                  0.785  <.001   0.784   <.001 
MDdx                  0.940  <.001   0.942   <.001 
 
MAsin                  0.880  <.001   0.872   <.001 
MDsin                 0.974  <.001   0.975   <.001 
 
MAavg                0.870  <.001   0.865   <.001    
MDavg                0.970  <.001   0.971   <.001 
                                                       
Masseter area right side (MAdx), masseter density right side (MDdx, masseter area left side (MAsin), masseter 
density left side (MDsin), average masseter average area (MAavg) and average masseter density (MDavg). 
a Model: Intraclass correlation coefficient (ICC), two-way random consistency. b Model: Intraclass correlation 
coefficient (ICC) two-way random absolute.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 28 
 
Table 4. Univariable Cox regression analysis of the effect of risk factors and preoperative 
masseter area and teeth measured from CT angiography images on long-term survival in 
carotid endarterectomy patients.                                          
                      ___Univariable    _           
Risk factor                  HR   (95% CI)       p             
Age                            1.06 (1.03-1.08)   <.001                
Female                       1.01 (0.65-1.55)   0.978 
BMI                       0.93 (0.87-1.01)   0.070 
BSA                       0.65 (0.24-1.78)   0.400 
DM                       1.15 (0.75-1.75)   0.519 
HTA                       0.91 (0.57-1.44)   0.676 
Cardiac                       1.32 (0.89-1.97)   0.170 
Dyslipidemia               0.74 (0.50-1.10)   0.137 
Pulmonary                  1.57 (0.81-3.04)   0.179 
Renal                       2.60 (0.95-7.09)   0.063       
PAD                       1.47 (0.89-2.42)   0.133 
Smoking                     0.85 (0.54-1.34)   0.482 
IL-stenosis                 2.32 (1.14-4.69)   0.020 
CL-stenosis                1.08 (0.86-1.37)   0.505 
Indication                   1.43  (1.07-1.92)   0.016 
Teeth                       0.67 (0.49-0.92)   0.012 
Side (L/R)                   0.70 (0.46-1.10)   0.100 
MAavg                       0.72 (0.59-0.88)   <.001 
MDavg                       0.92 (0.76-1.12)   0.423                        
Cox regression proportional hazards analysis. Hazard Ratio (HR), Confidence Interval (CI), Average masseter 
area (MAavg), average masseter density (MDavg), female relative to male gender (Female), Body Mass Index 
(BMI), Body Surface Area (BSA), diabetes mellitus (DM), hypertension (HTA), cardiac risk factor (diagnosis of 
myocardial infarction, coronary intervention, angina pectoris or ischemia on electrocardiography and 
congestive heart failure), pulmonary risk factor (Pulmonary), renal risk factor (diagnosed renal insufficiency, 
peripheral arterial disease (PAD), current smoking (Smoking), ipsilateral (IL), contralateral (CL). Indication 
category: 1) asymptomatic, 2) amaurosis fugax, 3) TIA, 4) stroke. The reported hazard ratios for masseter area 
and density parameters correspond to 1 standard deviation increase. The presence of teeth was scored in 
three categories: 1) no teeth, 2) any missing teeth and 3) no evidence of missing teeth. Operation side left (L), 
right (R). 
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Table 5. Multivariable Cox regression analysis of the effect of risk factors and preoperative 
masseter area and teeth measured from CT angiography images on long-term survival in 
carotid endarterectomy patients.                                          
             
Risk factor  HR   (95% CI)       p         
________________________________________________________________________________________ 
Age            1.05 (1.02-1.07)   0.001 
Gender       0.72 (0.45-1.15)   0.171 
Renal         2.63  (0.91-7.59)   0.073 
Indication   1.24  (0.93-1.67)   0.150 
IL-stenosis 1.91  (0.95-3.84)   0.070 
Teeth         0.74 (0.53-1.05)   0.093 
MAavg       0.76 (0.61-0.96)   0.023 
Cox regression proportional hazards analysis. Hazard Ratio (HR), Confidence Interval (CI), average masseter 
area (MAavg), female relative to male gender (Female), Body Mass Index (BMI), renal risk factor (diagnosed 
renal insufficiency), ipsilateral (IL), Indication category: 1) asymptomatic, 2) amaurosis fugax or TIA, 3) stroke. 
The reported hazard ratio for masseter area parameter corresponds to 1 standard deviation increase. The 
presence of teeth was scored in three categories: 1) no teeth, 2) any missing teeth and 3) no evidence of 
missing teeth. 
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Supplementary table 1. Characteristics of included and excluded carotid endarterectomy 
patients. 
 
                                           Study patients  Excluded patients 
                                        
Risk factor                           n=242               n=140                    p   
 
Age, median (IQR)              71.0  (13.0)      70 (14.0)               0.100        
Female, n (%)                      72     (29.8)      35   (24.6)             0.260 
DM, n (%)                            71     (29.3)      34   (23.9)             0.233   
HTA, n (%)                          186   (76.9)      105 (73.9)             0.549            
Cardiac, n (%)                     128   (52.9)      70   (49.3)             0.494            
Dyslipidemia, n (%)             135   (55.8)      89   (62.7)             0.165            
Renal, n (%)                        5       (2.1)        5     (3.5)               0.395            
PAD, n (%)                          37     (15.3)      20   (14.1)             0.724            
Pulmonary, n (%)                 25     (10.3)      17   (12.0)             0.639              
Smoking, n (%)                    68     (28.1)      48   (33.8)             0.226             
 
IL-stenosis                                                                                0.915                                       
<50%, n (%)                        2       (0.8)        1      (0.9)               
50-69%, n(%)                      28     (12.4)      13    (11.8)             
70-99%, n (%)                     212   (87.6)      96    (87.3)               
100%, n (%)                        0       (0)           0      (0)              
 
CL-stenosis                                                                              0.206 
<50%, n (%)                       134    (55.3)      69    (62.2)                  
50-69%, n (%)                    64     (26.4)       20    (18.0)             
70-99%, n (%)                    34      (14.0)      21    (18.9) 
100%, n (%)                       10      (4.1)        1      (0.9) 
 
Indication                                                                                 0.733 
Asymptomatic, n (%)          32      (13.2)      20    (14.1)                 
Amaurosis, n (%)                41      (16.9)      29    (20.4)              
TIA, n (%)                           85      (35.1)      51    (35.8)               
Ischemic stroke, n (%)        84      (34.7)      42    (29.6)           
  
Diabetes mellitus (DM), hypertension (HTA), cardiac risk factor (diagnosis of myocardial infarction, coronary 
intervention, angina pectoris, ischemia on electrocardiography and congestive heart failure), renal risk factor 
(diagnosis of renal insufficiency), peripheral arterial disease (PAD), ipsilateral (IL), contralateral (CL), transient 
ischemic attack (TIA). 
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Supplementary table 2. Detailed radiological characteristics of carotid endarterectomy 
patients. 
 
               n      mean     SD     95%CI           median    IQR                                   
                              
MAdx,     242  397.3     79.4   387.2-407.3   389.7       117.7 
MAsin      242  397.5     79.1   387.5-407.5   396.5       111.8 
MAavg    242  397.4     76.8   387.7-407.1   394.0       110.1 
 
MDdx      242  52.1      11.9   50.6-53.6       53.0        16.3 
MDsin     242  52.3      12.8   50.7-53.9       54.0        17.0 
MDavg    242  52.2      11.9   50.7-53.7       53.5        16.5 
 
Masseter area right side (MAdx, mm2), Hounsfield Unit (HU), masseter density right side (MDdx, HU), 
masseter area left side (MAsin, mm2), masseter density left side (MDsin, HU), average masseter average area 
(MAavg, mm2) and average masseter density (MDavg, HU). 
MULTIPLE CHOICE QUESTIONS 
 
1. Masseter area 
a. Can be measured from CTA images 
b. Can be reliably measured without tilt correction 
c. Must be measured after tilt correction 
d. Is associated with body surface area 
e. Is not associated with dental status 
2. Masseter area 
a. Is not a predictor of postoperative mortality after carotid endarterectomy 
b. Is a predictor of postoperative mortality after carotid endarterectomy 
c. Is a predictor of postoperative mortality but not independent of age, gender, BMI, renal 
insufficiency, ipsilateral stenosis, indication category and presence of teeth 
d. Is a predictor of postoperative mortality  independent of age, gender, BMI, renal 
insufficiency, ipsilateral stenosis, indication category and presence of teeth 
e. Age is associated with masseter area 
 
 
 
  
 
